Cargando…
Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
One of the most common chromosomal translocations in acute myeloid leukemia is t(8;21)(q22;q22), which results in the appearance of abnormal transcripts encoding for the fusion protein RUNX1-ETO. Therefore, this oncoprotein is considered to be a pertinent and promising target for treating t(8;21) le...
Autores principales: | Spirin, Pavel, Lebedev, Timofey, Orlova, Natalia, Morozov, Alexey, Poymenova, Nadezhda, Dmitriev, Sergey E., Buzdin, Anton, Stocking, Carol, Kovalchuk, Olga, Prassolov, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593619/ https://www.ncbi.nlm.nih.gov/pubmed/28915648 http://dx.doi.org/10.18632/oncotarget.18503 |
Ejemplares similares
-
Identification of cell type–specific correlations between ERK activity and cell viability upon treatment with ERK1/2 inhibitors
por: Lebedev, Timofey D., et al.
Publicado: (2022) -
Growth factor signaling predicts therapy resistance mechanisms and defines neuroblastoma subtypes
por: Lebedev, Timofey, et al.
Publicado: (2021) -
Immunoproteasome Activity and Content Determine Hematopoietic Cell Sensitivity to ONX-0914 and to the Infection of Cells with Lentiviruses
por: Vagapova, Elmira, et al.
Publicado: (2021) -
Subtype of Neuroblastoma Cells with High KIT Expression Are Dependent on KIT and Its Knockdown Induces Compensatory Activation of Pro-Survival Signaling
por: Lebedev, Timofey, et al.
Publicado: (2022) -
PB1760: PREDICTION OF DRUG SENSITIVITY AND GENETIC VULNERABILITY FOR ACUTE LEUKEMIA SUBTYPES USING GRAPH OF SIGNALING PATHWAY CORRELATIONS.
por: Lebedev, Timofey, et al.
Publicado: (2023)